908 Devices (MASS) Competitors

Transcat (NASDAQ:TRNS) and 908 Devices (NASDAQ:MASS) are both small-cap measuring and control equipment companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, valuation, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk.

Do analysts rate TRNS or MASS?

Transcat currently has a consensus price target of $112.20, suggesting a potential upside of 34.44%. 908 Devices has a consensus price target of $5.33, suggesting a potential downside of 21.34%. Given Transcat's stronger consensus rating and higher probable upside, equities analysts plainly believe Transcat is more favorable than 908 Devices.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Transcat	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60
908 Devices	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50

Does the media refer more to TRNS or MASS?

In the previous week, 908 Devices had 2 more articles in the media than Transcat. MarketBeat recorded 4 mentions for 908 Devices and 2 mentions for Transcat. Transcat's average media sentiment score of 0.48 beat 908 Devices' score of 0.41 indicating that Transcat is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Transcat	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
908 Devices	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has preferable valuation & earnings, TRNS or MASS?

Transcat has higher revenue and earnings than 908 Devices. 908 Devices is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Transcat	$278.42M	2.79	$14.52M	$1.56	53.50
908 Devices	$59.63M	4.08	-$72.21M	-$0.54	-12.56

Is TRNS or MASS more profitable?

Transcat has a net margin of 5.21% compared to 908 Devices' net margin of -28.80%. Transcat's return on equity of 6.47% beat 908 Devices' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Transcat	5.21%	6.47%	5.02%
908 Devices	-28.80%	-27.10%	-20.49%

Which has more risk and volatility, TRNS or MASS?

Transcat has a beta of 0.73, meaning that its stock price is 27% less volatile than the S&P 500. Comparatively, 908 Devices has a beta of 0.38, meaning that its stock price is 62% less volatile than the S&P 500.

Do institutionals & insiders hold more shares of TRNS or MASS?

98.3% of Transcat shares are held by institutional investors. Comparatively, 88.1% of 908 Devices shares are held by institutional investors. 2.3% of Transcat shares are held by company insiders. Comparatively, 23.7% of 908 Devices shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Transcat beats 908 Devices on 13 of the 16 factors compared between the two stocks.